Leonhart v. Nature’s Path Foods, No. 5:13cv492 (N.D. Cal.): The court granted defendant’s motion to dismiss with leave to amend in a putative class action alleging claims under California’s UCL, FAL, and CLRA claiming that several of cefendant’s products were misbranded with respect to a) ECJ, b) unapproved health or drug claims, c) “low sodium”

Yesterday the Supreme Court heard oral argument in this case.  The transcript of the argument is available here.  Pom brought this suit against Coca-Cola under the federal Lanham Act, alleging that Coca-Cola’s label (see page 7 of Pom’s petition for certiorari) of its “Pomegranate Blueberry” juice was deceptive and misleading to consumers when

Gitson v. Trader Joe’s Co., No. 3:13-cv-01333 (N.D. Cal.): The court granted in part a motion to dismiss putative class action claims that the defendant’s products are misleadingly labeled in that they label some products as containing evaporated cane juice, label non-milk products as “milk,” and contain undisclosed preservatives.  The court reaffirmed its view that

Lilly v. Conagra Foods Inc., No. 12-55921 (9th Cir.): Plaintiff appealed dismissal of her putative class action complaint on federal preemption grounds.  Plaintiff had alleged claims under California’s consumer protection and unfair competition laws, contending that the labeling of defendant’s sunflower seed products misleadingly provided a lower sodium content than the product contained.  The panel

Koenig v. Boulder Brands, Inc., No. 1:13-cv-01186-ER (S.D.N.Y.):  In a putative class action over “fat free” labeling on defendants’ Smart Balance milk products, the court held that nonbinding FDA opinions do not preempt state law claims.  Plaintiffs alleged the “fat free” labeling of Smart Balance milk products infused with a blend of omega-3 fatty acids

On November 8, 2013, the FDA published a tentative determination that partially hydrogenated oils (PHO), which are the primary dietary source of industrially-produced trans fatty acids, are not generally recognized as safe (GRAS) for any use in food based on current scientific evidence. If this determination is finalized by the FDA, the result would be that PHO is considered a food additive that may be used in food only with prior FDA approval. The FDA cited scientific evidence that consumption of PHO significantly increases a number of health risks, principally heart disease.
Continue Reading Regulatory Update Regarding Trans Fats